Evidence-Based Medicine Guidelines
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Selective Serotonin Reuptake Inhibitors (SSRIs) for Autism Spectrum Disorders." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders.
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders. Accessed December 4, 2023.
Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders
Selective Serotonin Reuptake Inhibitors (SSRIs) for Autism Spectrum Disorders [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders
ID - 457091
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457091/all/Selective_serotonin_reuptake_inhibitors__SSRIs__for_autism_spectrum_disorders
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
